The Epidemiology of Hepatitis C Virus Antibody in Yemen

Daniel A. ScottUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Daniel A. Scott in
Current site
Google Scholar
PubMed
Close
,
Niel T. ConstantineUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Niel T. Constantine in
Current site
Google Scholar
PubMed
Close
,
Johnny CallahanUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Johnny Callahan in
Current site
Google Scholar
PubMed
Close
,
James P. BuransUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by James P. Burans in
Current site
Google Scholar
PubMed
Close
,
James G. OlsonUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by James G. Olson in
Current site
Google Scholar
PubMed
Close
,
Mohamed Al-FadeelUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Mohamed Al-Fadeel in
Current site
Google Scholar
PubMed
Close
,
Hussein Al-OziebUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Hussein Al-Ozieb in
Current site
Google Scholar
PubMed
Close
,
H. ArunkumerUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by H. Arunkumer in
Current site
Google Scholar
PubMed
Close
, and
Kenneth C. HyamsUS Naval Medical Research Unit No. 3, Ministry of Health, US Naval Medical Research Institute, Cairo, Egypt

Search for other papers by Kenneth C. Hyams in
Current site
Google Scholar
PubMed
Close
Restricted access

A cross-sectional survey of 348 subjects without evidence of liver disease was conducted to investigate the prevalence and risk factors for hepatitis C virus antibody (anti-HCV) seropositivity in the Yemen Arab Republic. The mean age of study subjects was 28.7 years (range 3–80), and 61% were males. Using commercial enzyme-linked immunosorbent assays (ELISA), 6.0% (95% confidence interval [CI] 3.8–9.1) of subjects were anti-HCV—positive, 13.5% were hepatitis B surface antigen-positive (HBsAg—positive), and 51.4% were positive for at least one serologic marker of prior hepatitis B infection. Nine (2.6%; 95% CI 1.2–4.9) of the 21 ELISA-positive sera were confirmed to be anti-HCV positive by a recombinant immunoblot assay. Anti-HCV seropositivity was significantly associated with age (odds ratio [OR] 2.0 for each 10-year increase in age) and prior surgery (OR 10.1), but was not associated with a history of prior blood transfusion or markers of hepatitis B infection. These preliminary data suggest that hepatitis C may pose a substantial health threat in Yemen.

Save